Literature DB >> 2188396

Identification of a CD4 homologue in the cat.

C D Ackley1, E A Hoover, M D Cooper.   

Abstract

Monoclonal antibody, Fel 7, produced against cat T cells, was found to react with a single-chain glycoprotein of Mr 65,000 present on a majority of the thymocytes, 40% of lymph node cells, 15% of splenocytes and 25% of blood mononuclear cells. Using a previously reported antibody that recognizes the feline CD8 antigen, approximately 65% of cat thymocytes were shown to express both the Fel 7 and fCD8 antigens, while 14% and 6% expressed either the Fel 7 or the fCD8 determinant respectively. The Fel 7 and fCD8 antigens were expressed by mutually-exclusive subpopulations of peripheral T cells, and not by B cells, macrophages or other types of blood cells. Expression of the Fel 7 antigen was down-regulated and the molecule was phosphorylated when T cells were stimulated with phorbol ester, while the expression of the fCD8 antigen was unaffected by this treatment. The addition of soluble Fel 7 antibodies efficiently blocked Con A-induced proliferation of T cells in a dose-dependent manner. The data suggest that the mAb Fel 7 identifies a feline CD4 homologue, providing an important reagent for the study of normal and abnormal T cell development in cats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188396     DOI: 10.1111/j.1399-0039.1990.tb01762.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  26 in total

1.  Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.

Authors:  D L Lerner; J H Elder
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Isolation and characterization of three subpopulations of IgG in the common cat (Felis catus).

Authors:  C I Baldwin; D A Denham
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

Review 4.  Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Authors:  Brian J Willett; Margaret J Hosie
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

5.  Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects.

Authors:  R A Olmsted; R Langley; M E Roelke; R M Goeken; D Adger-Johnson; J P Goff; J P Albert; C Packer; M K Laurenson; T M Caro
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.

Authors:  B J Willett; M J Hosie; J J Callanan; J C Neil; O Jarrett
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

7.  A cDNA encoding feline CD4 has a unique repeat sequence downstream of the V-like region.

Authors:  J Norimine; T Miyazawa; Y Kawaguchi; Y Tohya; C Kai; T Mikami
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9.

Authors:  B J Willett; M J Hosie; O Jarrett; J C Neil
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

9.  Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.

Authors:  W Song; E W Collisson; P M Billingsley; W C Brown
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

10.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.